Sean Peng, Ph.D.
Founder and President

  • Dr. Sean Peng is an accomplished scientist with more than twenty years of pharmaceutical industry experience.  He has successfully built and managed bioanalysis and ADME/PK operations supporting drug discovery, preclinical evaluation, and clinical development in small and large pharmaceutical companies.
  • Dr. Peng has extensive expertise in bioanalysis, in vitro ADMET, in vivo PK/TK, formulation development, PK/PD simulation/modeling, and interspecies PK scaling. Prior to founding Touchstone Biosciences Company, he held technical and leadership positions of increasing responsibility at Procter & Gamble, Johnson & Johnson, and Galleon Pharmaceuticals.
  • Dr. Peng obtained his Ph.D. from the University of Illinois at Urbana-Champaign. He has published more than fifty peer-reviewed research articles, invited reviews and book chapters, and received an AAPS award for his work on hyphenated separation technologies.